T. C. Efrata, “R&D INTENSITY AND IPO UNDERPRICING: CASE STUDY ON PHARMACEUTICAL AND BIOTECH INDUSTRIES IN THE US”, JAI, vol. 9, no. 1, pp. 1–21, Feb. 2016.